- Home
- JHI vs TNYA Comparison
JHI vs TNYA Comparison
Compare JHI & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JHI
- TNYA
- Stock Information
- Founded
- JHI 1971
- TNYA 2016
- Country
- JHI United States
- TNYA United States
- Employees
- JHI N/A
- TNYA N/A
- Industry
- JHI Trusts Except Educational Religious and Charitable
- TNYA Medicinal Chemicals and Botanical Products
- Sector
- JHI Finance
- TNYA Health Care
- Exchange
- JHI Nasdaq
- TNYA Nasdaq
- Market Cap
- JHI 124.3M
- TNYA 119.2M
- IPO Year
- JHI N/A
- TNYA 2021
- Fundamental
- Price
- JHI $14.09
- TNYA $1.30
- Analyst Decision
- JHI
- TNYA Strong Buy
- Analyst Count
- JHI 0
- TNYA 4
- Target Price
- JHI N/A
- TNYA $17.33
- AVG Volume (30 Days)
- JHI 29.5K
- TNYA 3.8M
- Earning Date
- JHI 01-01-0001
- TNYA 03-17-2025
- Dividend Yield
- JHI 6.80%
- TNYA N/A
- EPS Growth
- JHI N/A
- TNYA N/A
- EPS
- JHI 1.05
- TNYA N/A
- Revenue
- JHI N/A
- TNYA N/A
- Revenue This Year
- JHI N/A
- TNYA N/A
- Revenue Next Year
- JHI N/A
- TNYA N/A
- P/E Ratio
- JHI $12.47
- TNYA N/A
- Revenue Growth
- JHI N/A
- TNYA N/A
- 52 Week Low
- JHI $11.63
- TNYA $0.99
- 52 Week High
- JHI $13.40
- TNYA $7.01
- Technical
- Relative Strength Index (RSI)
- JHI 57.83
- TNYA 34.72
- Support Level
- JHI $13.84
- TNYA $1.43
- Resistance Level
- JHI $14.17
- TNYA $1.63
- Average True Range (ATR)
- JHI 0.11
- TNYA 0.12
- MACD
- JHI 0.04
- TNYA 0.02
- Stochastic Oscillator
- JHI 84.62
- TNYA 0.00
About JHI John Hancock Investors Trust
John Hancock Investors Trust is a United States-based diversified, closed-end management investment company. It seeks to generate income for distribution to its shareholders. The secondary objective of the company is capital appreciation. The portfolio composition of the fund comprises corporate bonds, U.S. government agencies, preferred securities, asset-backed securities, common stocks, short-term investments, and others.
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration, and precision medicine.